Avner Dor
CEO, Founder
CEO, Founder
Dor Pharmaceutical Service
Israel
Biography
vner joined the pharmaceutical industry in Regulatory Affairs as a Qualified Person for Luxembourg Pharmaceuticals in 1997. He served as Regulatory Affairs Manager with Trima Israel, one of the leading generic manufacturers in Israel, followed by 6 years with Pfizer Israel as Regulatory Affairs Manager, Head of Pharmacovigilance and Quality Assurance, and as Director of Clinical Operations before establishing Dor Pharmaceutical Services in 2011. Avner is well-respected in the Israeli Regulatory Affairs and Clinical Trials communities by regulators and colleagues. He has earned a reputation for integrity and efficient, effective support throughout full project lifecycles and beyond. Avner is certified as a Registered Pharmacist, Israeli Regulatory Affairs Manager and Israeli Qualified Person. He is also a member of the Pharmaceutical society of Israel and the Israeli PDA (Parenteral Drug Association). He is an Israeli QPPV (Qualified Person for Pharmacovigilance) for global pharmaceutical companies.
Research Interest
vner joined the pharmaceutical industry in Regulatory Affairs as a Qualified Person for Luxembourg Pharmaceuticals in 1997. He served as Regulatory Affairs Manager with Trima Israel, one of the leading generic manufacturers in Israel, followed by 6 years with Pfizer Israel as Regulatory Affairs Manager, Head of Pharmacovigilance and Quality Assurance, and as Director of Clinical Operations before establishing Dor Pharmaceutical Services in 2011. Avner is well-respected in the Israeli Regulatory Affairs and Clinical Trials communities by regulators and colleagues. He has earned a reputation for integrity and efficient, effective support throughout full project lifecycles and beyond. Avner is certified as a Registered Pharmacist, Israeli Regulatory Affairs Manager and Israeli Qualified Person. He is also a member of the Pharmaceutical society of Israel and the Israeli PDA (Parenteral Drug Association). He is an Israeli QPPV (Qualified Person for Pharmacovigilance) for global pharmaceutical companies.
